Quality of Life as an Integrative Indicator of Health Status in Patients with Chronic Hepatitis C and Concomitant Diabetes Mellitus Type II

Oleksandra Marynchak, Oleksandra Pryshliak, Oksana Kopchak, Iryna Hrynchyshyn, Ludmyla Byderkevych

Abstract


The main indicators of quality of life in patients with chronic hepatitis C with concomitant diabetes mellitus type II were studied on the basis of SF-36. A sharp decrease in physical and mental health was observed in patients with combined comorbidity in comparison with the group of patients without concomitant diabetes mellitus type II. Improvement of the patients’ quality of life by all parameters was detected under the influence of alpha-lipoic acid and lactulose use in addition to antiviral therapy.


Keywords


chronic hepatitis C; diabetes mellitus; quality of life; treatment

Full Text:

HTML PDF

References


Anastasiy IA. 60 konferentsiya amerikanskogo obshchestva po izucheniyu boleznei pecheni. Suchasni infektsii. 2010;1:127–133

Borisov VA, Sanin BI, Samsonova SE. [The experience of domestic antiviral agents, and some of own approaches in the treatment of chronic hepatitis C in adults]. Epidemiologiya i infektsionnye bolezni. 2015;3:4–10

Byeverov AO, Maevskaya MV. Khronicheskiy hepatit C i sochetannaya patologiya pecheni. Klinicheskie perspektivy hastroenterologii, hepatologii. 2008;6:9–17

Beloborodova EI, Lambrova EG, Beloborodova EV, et al. Pokazateli kachestva zhyzni u patsientov s khronicheskimi virusnymi hepatitami. Terapevticheskiy arkhiv. 2010;82 (11):41–45

Derbak MA. [Treatment of chronic hepatitis C in patients with diabetes type 2]. Naukovyi visnyk Uzhhorodskoho universytetu. 2013;1:24–27

Drapchak IM. Features of life quality evaluation in people with chronic liver diseases. Galic'kij likars'kij visnik. 2015;22 (4):16–19

Zhidkikh VN. Hepatit C – problema sovremennoi meditsiny (letsiya dlya vrachei). Medyko-sotsialni problem simii. 2009;14 (3):254–261

Kozko VN, Antsyferova NV, Solomennik AO. [Clinical and epidemiological features of chronic hepatitis C at present]. Mezhdunarodnyi meditsinskiy zhurnal. 2013;3:69–72

Kuznetsova AV, Dyachenko SV, Ostrovskiy AB, et al. Sravnitelnyi ekonomicheskiy analiz izmeneniya kachestva zhyzni pod vliyaniem pegilirovannykh interferonov pri khronicheskom hepatite C. Klinicheskie perspektivy hastroenterologii, hepatologii. 2012;5:41–46

Serheeva TA. Hepatyt C: vid spetsyfichnoi diahnostyky do kontroliu nad infektsiieiu. Profilaktychna medytsyna. 2014;3-4:80–81

Ushenina LA, Ryabokon OV. [Clinical-biochemical and morphological features of chronic hepatitis C at infectious different genotypes HCV]. Patolohiia. 2009;6 (1):86–89

Romero-Gomez M. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology. 2005;128(3):636–641. DOI: http://doi.org/10.1053/j.gastro.2004.12.049 [PMid: 15765399]

Ware JE, Snow KK, Kosinski MM, Gandek B. SF–36 Health Survey. Manual and interpretation guide. Boston, Mass: The Health Institute, New England Medical Center; 1993. 218 p.




DOI: http://dx.doi.org/10.21802/acm.2016.2.5

Refbacks

  • There are currently no refbacks.




Copyright (c) 2016 Oleksandra Marynchak, Oleksandra Pryshliak, Oksana Kopchak, Iryna Hrynchychyn, Ludmyla Byderkevych

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


IFNMU Logo

Free counters!